These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32927635)

  • 1. Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay.
    Bedi S; Garcia E; Jeyarajah EJ; Shalaurova I; Perez-Matos MC; Jiang ZG; Dullaart RPF; Matyus SP; Kirk WJ; Otvos JD; Davidson WS; Connelly MA
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32927635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis.
    Hu K; Perez-Matos MC; Argemi J; Vilar-Gomez E; Shalaurova I; Bullitt E; Landeen L; Sugahara G; Deng H; Mathur K; Tran S; Cai H; He H; Yalcin Y; Vieira Barbosa J; Ventura-Cots M; Marx K; Gad AP; Niezen S; Izunza Barba S; Ang LH; Popov YV; Fricker Z; Lai M; Curry M; Afdhal N; Szabo G; Mukamal KJ; Sanyal AJ; Otvos JD; Malik R; Saito T; Connelly MA; Chalasani NP; Bataller R; Jiang ZG
    Hepatology; 2022 Apr; 75(4):968-982. PubMed ID: 34662439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma.
    Bekaert ED; Alaupovic P; Knight-Gibson C; Norum RA; Laux MJ; Ayrault-Jarrier M
    Biochim Biophys Acta; 1992 Jun; 1126(1):105-13. PubMed ID: 1606170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins.
    Seidel D; Alaupovic P; Furman RH; McConathy WJ
    J Clin Invest; 1970 Dec; 49(12):2396-407. PubMed ID: 5480863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipoproteinaemia of liver disease.
    Miller JP
    Baillieres Clin Endocrinol Metab; 1990 Dec; 4(4):807-32. PubMed ID: 2082907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.
    Dashti N; Alaupovic P; Knight-Gibson C; Koren E
    Biochemistry; 1987 Jul; 26(15):4837-46. PubMed ID: 2822101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.
    Seidel D; Alaupovic P; Furman RH
    J Clin Invest; 1969 Jul; 48(7):1211-23. PubMed ID: 4978447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.
    Bekaert ED; Alaupovic P; Knight-Gibson CS; Franceschini G; Sirtori CR
    J Lipid Res; 1993 Jan; 34(1):111-23. PubMed ID: 8445335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro.
    O K; Frohlich J
    J Lipid Res; 1995 Nov; 36(11):2344-54. PubMed ID: 8656072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
    Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein.
    van den Berg EH; Flores-Guerrero JL; Gruppen EG; Garcia E; Connelly MA; de Meijer VE; Bakker SJL; Blokzijl H; Dullaart RPF
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-density lipoprotein buoyant density and cholesterol content on the formation of lipoprotein(a) particles.
    Becker L; Gabel BR; Spencer CA; Marcovina SM; Koschinsky ML
    Clin Exp Med; 2001 Jun; 1(2):121-5. PubMed ID: 11699729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A High-Throughput NMR Method for Lipoprotein-X Quantification.
    Garcia E; Shalaurova I; Matyus SP; Freeman LA; Neufeld EB; Sampson ML; Zubirán R; Wolska A; Remaley AT; Otvos JD; Connelly MA
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetes.
    Igau B; Lestavel S; Clavey V; Slomianny C; Drouin P; Bresson R; Fruchart JC; Duriez P; Fiévet C
    Atherosclerosis; 1996 Feb; 120(1-2):209-19. PubMed ID: 8645362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein Z].
    Kajiyama G; Otsuki T; Kawanishi M
    Nihon Rinsho; 1994 Dec; 52(12):3084-9. PubMed ID: 7853693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein-X fifty years after its original discovery.
    Fellin R; Manzato E
    Nutr Metab Cardiovasc Dis; 2019 Jan; 29(1):4-8. PubMed ID: 30503707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial lecithin:cholesterol acyltransferase deficiency: further resolution of lipoprotein particle heterogeneity in the low density interval.
    Guérin M; Dolphin PJ; Chapman MJ
    Atherosclerosis; 1993 Dec; 104(1-2):195-212. PubMed ID: 8141844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.